PTEN |
Tumor suppressor |
Deletion |
77% (17/22) |
0% (0/17) |
34% (11/32) |
Increased cell proliferation and reduced cell death due to dysfunction in cell cycle regulation |
RB1 |
Tumor suppressor |
Hemizygous Deletion |
0% (0/22) |
23% (4/17) |
0% (0/32) |
Excessive cell growth due to dysregulation of cell cycle inhibition |
TP53 |
Tumor suppressor |
Deletion |
68% (15/22) |
82% (14/17) |
0% (0/32) |
Dysfunction in DNA repair activation, cell cycle inhibition, activation of apoptosis and senescence response to short telomeres |
ATM |
Coordinates DNA repair |
Deletion |
77% (17/22) |
94% (16/17) |
47% (15/32) |
Dysfunction in recognition of DNA damage and activation of DNA repair pathways |
BRCA1 |
Tumor suppressor DNA repair |
Deletion |
9% (2/22) |
29% (5/17) |
9% (3/32) |
Dysfunction in repairing damaged DNA properly. Cell can no longer sense DNA damage and sent appropriate signals |
BRCA2 |
Tumor suppressor DNA repair |
Hemizygous deletion |
0% (0/22) |
23% (4/17) |
0% (0/32) |
Dysfunction in repairing damaged DNA properly. BRCA2 directly binds DNA and interact with other protein to initiation strand invasion during repair |
CDK2 |
Cell cycle regulator |
Deletion |
36% (8/22) |
23% (4/17) |
9% (3/32) |
Dysfunction in cell cycle regulation specifically G1-S transition |
MLH1 |
DNA mismatch repair |
Deletion |
0% (0/22) |
2% (3/17) |
19% (6/32) |
Dysfunction in DNA specifically in recognition and initiation of mismatch repair, therefore, elevating spontaneous mutation rate |
NCOA2 |
Transcription co-regulator |
Amplification |
68% (15/22) |
100% (17/17) |
28% (9/32) |
Upregulation of DNA expression for nuclear hormone receptors such as AR and ESR1 |
MYC |
Transcription factor |
Amplification |
0% (0/22) |
12% (2/17) |
3% (1/32) |
Upregulation of many genes involved in cell proliferation and cellular transformation via DNA over-replication |
NKX3.1 |
Tumor suppressor |
Deletion |
73% (16/22) |
94% (16/17) |
50% (16/32) |
As a transcription factor with critical function in prostate development NKX3.1 deletion results in increase prostate epithelial cell growth |
AR |
Transcription factor |
Amplification |
0% (0/22) |
0% (0/17) |
0% (0/32) |
As a transcription factor, AR amplification results in DNA over expression of genes such as IGFR and PSA that promote cell proliferation |
ETV6 |
Transcription factor |
Deletion |
45% (10/22) |
41% (7/17) |
6% (2/32) |
As a transcription factor it interacts with DNA to mostly inhibit transcription of its target genes that regulate both differentiation and cell growth |
polyploidy |
— |
Numerical change in a whole set of chromosomes |
64% (14/22) |
0% (0/17) |
0% (0/32) |
Polyploidy occurs due to abnormal cell division and have associated with TP53 deletion |